212 related articles for article (PubMed ID: 196039)
21. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
Sundmacher R
Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
[TBL] [Abstract][Full Text] [Related]
22. [Arabinosyladenine in ophthalmology (author's transl)].
Colin J
J Fr Ophtalmol; 1981; 4(6-7):525-30. PubMed ID: 7028853
[TBL] [Abstract][Full Text] [Related]
23. Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits.
Kwon BS; Gangarosa LP; Park NH; Hull DS; Fineberg E; Wiggins C; Hill JM
Invest Ophthalmol Vis Sci; 1979 Sep; 18(9):984-8. PubMed ID: 90030
[TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
Meldrum JB; Gupta VS; Babiuk LA
Chemotherapy; 1980; 26(1):54-63. PubMed ID: 7353440
[TBL] [Abstract][Full Text] [Related]
26. [Adenine-arabinoside in the treatment of idu-resistant herpes simplex keratitis (author's transl)].
Colin J; Baikoff G; Chastel C; Renard G
J Fr Ophtalmol; 1979 Mar; 2(3):205-7. PubMed ID: 156754
[TBL] [Abstract][Full Text] [Related]
27. Trifluorothymidine versus adenine arabinoside in the treatment of herpes simplex keratitis.
Van Bijsterveld OP; Post H
Br J Ophthalmol; 1980 Jan; 64(1):33-6. PubMed ID: 6766733
[TBL] [Abstract][Full Text] [Related]
28. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
Smith SH; Shipman C; Drach JC
Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
[TBL] [Abstract][Full Text] [Related]
29. Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis.
Fardeau C; Langlois M; Mathys B; Rafales P; Nugier F; Godard V; Aymard M; Denis J
Curr Eye Res; 1991; 10 Suppl():151-8. PubMed ID: 1650663
[TBL] [Abstract][Full Text] [Related]
30. Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
O'Brien WJ
Curr Eye Res; 1986 Aug; 5(8):595-9. PubMed ID: 3489583
[TBL] [Abstract][Full Text] [Related]
31. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.
Bryson Y; Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Jul; 6(1):98-101. PubMed ID: 15828177
[TBL] [Abstract][Full Text] [Related]
32. Acycloguanosine: antiviral activity in the rabbit cornea.
Falcon MG; Jones BR
Br J Ophthalmol; 1979 Jun; 63(6):422-4. PubMed ID: 88955
[TBL] [Abstract][Full Text] [Related]
33. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
34. [Antiviral effects of 9-beta-D-arabinofuranosyl-2,6-diaminopurine against experimental herpetic keratitis].
Yamane S
Nippon Ganka Gakkai Zasshi; 1984 Mar; 88(3):586-94. PubMed ID: 6464878
[No Abstract] [Full Text] [Related]
35. [The virostatic effect of adenine-arabinoside monophosphate. Experimental findings and preliminary clinical experiences].
Werner GT; Bömer H; Metzger E; Sauer O; Schneider H; Schubert E; Treuner J
Fortschr Med; 1978 Aug; 96(32):1589-97. PubMed ID: 680620
[TBL] [Abstract][Full Text] [Related]
36. Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
Pavan-Langston D; Campbell R; Lass J
Am J Ophthalmol; 1978 Nov; 86(5):618-23. PubMed ID: 213976
[TBL] [Abstract][Full Text] [Related]
37. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
[TBL] [Abstract][Full Text] [Related]
38. Pathological findings of adenine arabinoside (ARA-A) and cytarabine (ARA-C) in the treatment of herpes simplex encephalitis in rabbit model.
Narang HK
Antiviral Res; 1982 May; 2(1-2):53-67. PubMed ID: 6285819
[TBL] [Abstract][Full Text] [Related]
39. Double-blind clinical trial of acyclovir and adenine arabinoside in herpetic corneal ulceration.
Young B; Patterson A; Ravenscroft T
Am J Med; 1982 Jul; 73(1A):311-2. PubMed ID: 7048918
[TBL] [Abstract][Full Text] [Related]
40. Antimetabolite drug therapy in herpes simplex.
Kaufman HE
Ophthalmology; 1980 Feb; 87(2):135-9. PubMed ID: 6247680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
